Research Paper Volume 13, Issue 17 pp 21671—21699

Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer


Figure 6. Internal validation of TfR1 as an independent prognostic factor for BC patients. (A) Univariate and multivariate Cox regression analyses determined TfR1 as an independent prognostic factor. (B) A prognostic nomogram integrating TfR1 expression and clinicopathologic variables was constructed to estimate OS. (C) Calibration plots to predict the OS of BC patients at 1, 3, and 5 years.